Mechanical Circulatory Support (MCS) Devices serve as a bridge to heart transplantation,
recovery, or lifelong support for patients at the end stage of Advanced Heart Failure
(AdHF). The inflammatory response after MCS implantation links to either successful
resolution of surgical injury or progression to multiorgan dysfunction (MOD) and death.
Main focus of this study is to develop a set of preoperative predictive biomarkers
to characterize inflammatory response and outcomes after MCS implantation.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of Heart and Lung TransplantationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2017 Published by Elsevier Inc.
